Aduro biotech Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Contact Us Aduro Have a question?

3 hours ago Adurolife.com

Aduro HQ. 17425 NE Union Hill RD. Suite 100. Redmond, WA 98052. Seeking Member Support? Member Support.

Website: https://adurolife.com/contact-us/

Category: Contact Support, Support NumberShow Details ››

Aduro BioTech Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com

(510) 848-4400Phone Number (510) 848-4400 Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases. It was founded in 2000 and headquartered in Berkeley, California.

Website: https://www.crunchbase.com/organization/aduro-biotech

Category: Phone Number, Tech SupportShow Details ››

adroex991_6.htm SEC

3 hours ago Sec.gov

510-809-2452Contact: Media Contact: Jennifer Lew . Aljanae Reynolds. Chief Financial Officer . 510-809-2452. 510-809-4816 . [email protected]aduro.com . Aduro Biotech Reports First Quarter 2018 Financial Results . BERKELEY, Calif., May 2, 2018 – Aduro Biotech, Inc. (NASDAQ: ADRO) today reported financial results for the first quarter ended March 31, 2018. Net loss

Website: https://www.sec.gov/Archives/edgar/data/1435049/000156459018010336/adro-ex991_6.htm

Category: Contact Support, Tech SupportShow Details ››

Aduro Biotech Company Profile Office Locations

Just Now Craft.co

Aduro Biotech has 152 employees across 3 locations and $827 K in annual revenue in FY 2020. See insights on Aduro Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Website: https://craft.co/aduro-biotech

Category: Tech SupportShow Details ››

ADURO BIOTECH, INC. (Form: DEF 14A, Received: 03/24/2020

2 hours ago Content.edgar-online.com

ADURO BIOTECH, INC. 740 Heinz Avenue. Berkeley, CA 94710. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS. To be held on May 5, 2020. Dear Stockholder: You are cordially invited to attend the Annual Meeting of Stockholders of Aduro Biotech, Inc., a Delaware corporation (the “Company”). The meeting will be held on Tuesday, May 5, 2020 at 9:00 a.m

Website: https://content.edgar-online.com/ExternalLink/EDGAR/0001564590-20-012526.html?hash=aa5eb847e941ef83bc532c75016a583ac52d1f3049ff00787fb86264d157b000&dest=ADRO-DEF14A_20200505_HTM)

Category: Tech SupportShow Details ››

ADURO BIOTECH, INC. REVERSE SPLIT OPTION SYMBOL: …

Just Now Infomemo.theocc.com

800-544-6091Aduro Biotech, Inc. (ADRO) has announced a 1-for-5 reverse stock split. As a result of the reverse stock [email protected] Clearing Members may contact Member Services at 1-800-544-6091 or, within Canada, at 1-800-424-7320, or email [email protected] Title:

Website: https://infomemo.theocc.com/infomemos?number=47665

Category: Contact Support, Tech SupportShow Details ››

Jobs with Aduro Biotech BioSpace

5 hours ago Biospace.com

Aduro’s B-select monoclonal antibody platform includes a number of immune modulating assets in research and preclinical development, including BION-1301, an anti-APRIL antibody. Aduro is collaborating with leading global pharmaceutical companies to expand its …

Website: https://www.biospace.com/employer/397207/aduro-biotech/

Category: Tech SupportShow Details ››

Aduro Biotech Stockholders Approve Merger Agreement with

2 hours ago Investors.aduro.com

One-for-Five Reverse Stock Split to be Effective October 2, 2020. BERKELEY, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation Inducing Ligand (APRIL) pathways for the treatment of cancer, …

Website: https://investors.aduro.com/news-releases/news-release-details/aduro-biotech-stockholders-approve-merger-agreement-chinook

Category: Tech SupportShow Details ››

Aduro Biotech Provides Business Update and Reports Second

2 hours ago Investors.aduro.com

BERKELEY, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the A Proliferation Inducing Ligand (APRIL) and Stimulator of Interferon Genes (STING) pathways for the treatment of cancer, autoimmune and inflammatory diseases, today provided a …

Website: https://investors.aduro.com/news-releases/news-release-details/aduro-biotech-provides-business-update-and-reports-second-0

Category: Tech SupportShow Details ››

Aduro Biotech and Chinook Therapeutics Announce Definitive

7 hours ago Globenewswire.com

Conference Call Details. Chinook and Aduro will host a live conference call and webcast on Tuesday, June 2, 2020, at 8:30 am EDT to discuss the …

Website: https://www.globenewswire.com/news-release/2020/06/02/2042120/0/en/Aduro-Biotech-and-Chinook-Therapeutics-Announce-Definitive-Merger-Agreement.html

Category: Tech SupportShow Details ››

Patents Assigned to Aduro Biotech, Inc. Justia Patents

3 hours ago Patents.justia.com

Patents Assigned to Aduro Biotech, Inc. COMPOSITIONS AND METHODS FOR ACTIVATING "STIMULATOR OF INTERFERON GENE"-DEPENDENT SIGNALLING. Publication number: 20200282049. Abstract: The present invention provides highly active cyclic-di-nucleotide (CDN) immune stimulators that activate DCs via a recently discovered cytoplasmic receptor known as

Website: https://patents.justia.com/assignee/aduro-biotech-inc

Category: Tech SupportShow Details ››

Aduro Biotech Announces First Quarter 2016 Financial

3 hours ago Investors.aduro.com

510 809 9264Contact: Sylvia Wheeler SVP, Corporate Affairs 510 809 9264 Media Contact: Angela Bitting 925 202 6211 [email protected]aduro.com Mike Beyer Sam Brown, Inc. 312 961 2502 Aduro Biotech, Inc. IR Contact

Website: https://investors.aduro.com/news-releases/news-release-details/aduro-biotech-announces-first-quarter-2016-financial-results

Category: Contact Support, Tech SupportShow Details ››

BioNovion Crunchbase Company Profile & Funding

9 hours ago Crunchbase.com

BioNovion is a biopharmaceutical company that specializes in immune oncology antibody discovery operations. The Company focuses on the development of antibodies for the immune therapy of cancer. BioNovion is a U.S.-based company that was founded in 2011. The company was acquired by Aduro BioTech on September 29, 2015.

Website: https://www.crunchbase.com/organization/bionovion

Category: Tech SupportShow Details ››

Lilly and Aduro Biotech Announce Research Collaboration

1 hours ago Investor.lilly.com

Aduro's B-select monoclonal antibody technology, including BION-1301, an anti-APRIL antibody, is comprised of a number of immune modulating assets in research and development. Aduro is collaborating with leading global pharmaceutical companies to expand its products and technologies. For more information, please visit www.aduro.com.

Website: https://investor.lilly.com/news-releases/news-release-details/lilly-and-aduro-biotech-announce-research-collaboration-and

Category: Tech SupportShow Details ››

ADURO BIOTECH, INC. (Form: 8K, Received: 10/01/2020 16:06:47)

3 hours ago Content.edgar-online.com

At the Special Meeting of Stockholders of Aduro Biotech, Inc. (the “Company” or “Aduro”) held on October 1, 2020, virtually, (the “Special Meeting”), as described below, the Company’s stockholders approved an amendment to the amended and restated certificate of incorporation of Aduro to effect a reverse stock split of Aduro’s issued and outstanding common stock within a range

Website: https://content.edgar-online.com/ExternalLink/EDGAR/0001193125-20-261293.html?hash=e1d704a006704e7b2e488b1d2bfe5ec805e5064ce209d52fe952cdfae05eac91&dest=D153950DEX31_HTM

Category: Tech SupportShow Details ››

Working at Aduro BioTech Glassdoor

1 hours ago Glassdoor.com

Glassdoor gives you an inside look at what it's like to work at Aduro BioTech, including salaries, reviews, office photos, and more. This is the Aduro BioTech company profile. All content is posted anonymously by employees working at Aduro BioTech.

Website: https://www.glassdoor.com/Overview/Working-at-Aduro-BioTech-EI_IE793405.11,24.htm

Category: Tech SupportShow Details ››

Aduro CEO Stephen Isaacs leaves exechange

9 hours ago Exechange.com

Aduro said: “In connection with the merger, Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will be stepping down.” Share price decline. The announcement follows a decline in Aduro Biotech Inc.’s share price of 87% since January 2016. In the position of CEO since 2008. Stephen Isaacs became CEO of the Company

Website: https://exechange.com/19742/aduro-ceo-stephen-isaacs-leaves

Category: Tech SupportShow Details ››

Aduro Biotech to Host Conference Call and Webcast

Just Now Finance.yahoo.com

Aduro Biotech to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 57th ERA-EDTA Virtual Congress Read full article May 19, 2020, 5:15 AM

Website: https://finance.yahoo.com/news/aduro-biotech-host-conference-call-121510416.html

Category: Tech SupportShow Details ››

Aduro Biotech 2021 Investment ADRO Macroaxis

Just Now Macroaxis.com

Aduro Biotech Stock Profile. Aduro Biotech, Inc., an immunotherapy company, focuses on the discovery, development, and commercialization of therapies to harness the bodys natural immune system for the treatment of patients with challenging diseases. Aduro Biotech, Inc. was founded in 2000 and is headquartered in Berkeley, California.

Website: https://www.macroaxis.com/stock/ADRO/Aduro-Biotech

Category: Tech SupportShow Details ››

Aduro Biotech and Chinook Therapeutics Announce Definitive

Just Now Benzinga.com

Chinook and Aduro will host a live conference call and webcast on Tuesday, June 2, 2020, at 8:30 am EDT to discuss the proposed transaction. To …

Website: https://www.benzinga.com/pressreleases/20/06/g16158015/aduro-biotech-and-chinook-therapeutics-announce-definitive-merger-agreement

Category: Tech SupportShow Details ››

Aduro Biotech Stockholders Approve Merger Agreement with

Just Now Biospace.com

Aduro Biotech Stockholders Approve Merger Agreement with Chinook Therapeutics. Published: Oct 01, 2020. BERKELEY, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADURO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and A Proliferation

Website: https://www.biospace.com/article/releases/aduro-biotech-stockholders-approve-merger-agreement-with-chinook-therapeutics/

Category: Tech SupportShow Details ››

Aduro Biotech (ADRO) May Report Negative Earnings: Know

5 hours ago Finance.yahoo.com

For the last reported quarter, it was expected that Aduro Biotech would post a loss of $0.21 per share when it actually produced a loss of $0.24, delivering a surprise of …

Website: https://finance.yahoo.com/news/aduro-biotech-adro-may-report-163404322.html

Category: Tech SupportShow Details ››

Aduro Biotech, Inc. DEF 14A Apr 28 2016 Seeking Alpha

9 hours ago Seekingalpha.com

ADURO BIOTECH, INC. (Name of Registrant as Specified In Its Charter) or contact your broker or bank to request a proxy form. the class and number of shares of each class of capital stock

Website: https://seekingalpha.com/filing/2770773

Category: Contact Support, Tech SupportShow Details ››

ADRO Aduro Biotech Stock Interactive Chart Barchart.com

1 hours ago Barchart.com

The number of points the security must move before a new brick is formed. Column : Much like Line and Area charts, a Column chart plots a vertical bar for the close. High/Low Price Markers: Charts are designed to indicate the high and low bars for the visible data range using a small "arc" on two bars:

Website: https://www.barchart.com/stocks/quotes/ADRO/interactive-chart

Category: Tech SupportShow Details ››

Please leave your comments here:

What kind of company is Aduro Biotech Inc?

Aduro Biotech, Inc. is an immunotherapy company focused on the discovery, development and commercialization of therapies that are intended to transform the treatment of challenging diseases.

How does Lilly work with Aduro Biotech?

Aduro will receive research funding during the research term and has the option to co-fund the clinical development of each product in exchange for an increase in royalty payments. Lilly will be responsible for all costs of global commercialization.

How does Aduro support employee health and safety?

Support employee mental and physical health and safety with Aduro’s corporate wellness solutions. In today’s world, people are facing an increasing number of wellness challenges, causing them to become more… A recent study by Gallup found that only 32% of employees in the U.S. feel engaged at work.

What do you need to know about Aduro connect?

Aduro Connect is a fun, inspiring platform that brings together expert coaching, interactive content, meaningful incentives and personalized data that drives engagement and insights about your organization’s population.

Brand New Updated

Wild West Domains Phone Number

Ihg Reservations Customer Service Number

Unity Technologies Sf Phone Number

Dynatrace

Access Health Ct Customer Service

American Home Shield Phone Customer Service

Discovery Benefits Employer Contact Number

Quantum3d.com

First United Bank Contact Number

Nationaltelesystems.com

Ornl Federal Credit Union Phone Number

Browse All Brands >>

Popular Brands

Abbvie
Amazon
Apple
Asml
Att
Aia
Adobe
Acc